Baylor College of Medicine;The Methodist Hospital D/B/A Houston Methodist
发明人:
GHEBRE, Yohannes T.,LUDWIG, Michell S.,BONNEN, Mark David,JHAVERI, Pavan Mukesh
申请号：
AU2019228575
公开号：
AU2019228575A1
申请日:
2019.02.28
申请国别(地区):
AU
年份:
2020
代理人:
摘要：
Embodiments of the disclosure include methods and compositions related to treatment or prevention of cancer therapy-induced tissue inflammation, dermatitis, and/or scarring. In particular embodiments one or more proton pump inhibitors are provided to an individual before, during, and/or after receiving anticancer therapy. In some embodiments one or more proton pump inhibitors are provided to an individual before, during, and/or after having a health conditions, allergies, genetic factors and/or exposure to one or more irritants.
